A study to survey adults in South Korea with cancer who receive PADCEV Injection, Trial ID 7465-PV-0001

Study summary

Enfortumab vedotin (or PADCEV Injection) is a treatment for cancer in the bladder lining (urothelial cancer). PADCEV Injection is now available to treat this cancer.

People in this study will be adults in South Korea with locally advanced or metastatic urothelial cancer. Metastatic means the cancer has spread to other parts of the body. During their care, the person’s doctor will have prescribed PADCEV Injection and other medicines to treat their cancer. People in the study will be treated according to their clinic’s standard practice. This study is about collecting information only.

This study will survey people who know they are receiving PADCEV Injection. The aims of the study are to check outcomes of treatment with PADCEV and record any medical problems during the study.

Once a doctor has prescribed PADCEV Injection, a person in the study will be observed for up to 48 weeks (about 1 year) after their first dose. During this time, a person’s medical records will be reviewed to check for any medical problems and to follow the condition of their cancer. If a person in the study stops taking PADCEV Injection sooner than 48 weeks, records will be reviewed until 30 days (1 month) after each person’s last dose of PADCEV Injection or until they start a different medicine for their cancer.

Additional Study Details

Phase

N/A

Product

Enfortumab Vedotin

Type

Observational

Masking

N/A

Enrollment number

228

Show Additional Study Details

Get more information

Would you like more information about clinical trial sites that are recruiting participants for A study to survey adults in South Korea with cancer who receive PADCEV Injection? Contact us by filling out your information to the right and we’ll respond to you.

Requestor Information [I am…]

A caregiver
A healthcare provider
A parent
A patient
A patient advocate

First name

Last Name

Country/Region

Algeria
Argentina
Armenia
Australia
Austria
Belarus
Belgium
Bosnia And Herzegovina
Brazil
Bulgaria
Canada
Chile
China
Colombia
Croatia
Czech Republic
Denmark
Dominican Republic
Egypt
Estonia
Finland
Former Serbia and Montenegro
France
Georgia
Germany
Greece
Guatemala
Hong Kong
Hungary
Iceland
India
Indonesia
Ireland
Israel
Italy
Japan
Jordan
Kazakhstan
Latvia
Lebanon
Lithuania
Macedonia
Malaysia
Mexico
Montenegro
Morocco
Netherlands
New Zealand
Norway
Panama
Peru
Philippines
Poland
Portugal
Puerto Rico
Republic of Korea
Republic of Moldova
Romania
Russian Federation
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
Spain
Sweden
Switzerland
Taiwan, Province of China
Thailand
Turkey
Ukraine
United Kingdom
United States
Vietnam

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

I give my consent to the processing of my personal data mentioned above according to Astellas Privacy Notice & Cookies Policy

Locations

Active, not recruiting

Site KR82004

Incheon, Incheon, Republic of Korea, 21565

Recruiting

Site KR82003

Seoul, Seoul, Republic of Korea, 03722

Recruiting

Site KR82002

Seoul, Seoul, Republic of Korea, 02841

Active, not recruiting

Site KR82001

Goyang-si, Gyeonggi-do, Republic of Korea, 10408

Recruiting

Site KR82005

Seoul, Seoul, Republic of Korea, 03181

Completed

Site KR82007

Jeollanam-do, Jeollanam-do, Republic of Korea, 58128

Completed

Site KR82010

Busan, Busan, Republic of Korea, 48108

Recruiting

Site KR82008

Suwon-si, Gyeonggi-do, Republic of Korea, 16500

Recruiting

Site KR82011

Seoul, Seoul, Republic of Korea, 07985

Completed

Site KR82009

Busan, Busan, Republic of Korea, 49201

Recruiting

Site KR82013

Jeonju-si, Jeonbuk-do, Republic of Korea, 54907

Recruiting

Site KR82006

Seoul, Seoul, Republic of Korea, 07417

Active, not recruiting

Site KR82017

Seoul, Seoul, Republic of Korea, 06351

Recruiting

Site KR82014

Daegu, Daegu, Republic of Korea, 42415

Completed

Site KR82015

Busan, Busan, Republic of Korea, 47392

Completed

Site KR82016

Busan, Busan, Republic of Korea, 50612

Recruiting

Site KR82012

Suwon-si, Gyeonggi-do, Republic of Korea, 16247

Recruiting

Site KR82018

Daejeon, Daejeon, Republic of Korea, 35365

Frequently Asked Questions

Are clinical trials only for people with advanced cancer?

While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

Will I have to stop my current treatment to participate in a clinical trial?

Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

Should I be worried about getting a placebo?

In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

Do I need a referral from my doctor to take part in a study?

Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

Explore More

A study to survey adults in South Korea with cancer who receive PADCEV Injection

Study summary

Additional Study Details

Get more information

Locations

Frequently Asked Questions

Explore More

What are clinical trials?

Why are Clinical Trials Important?

Why Participate in a Clinical Trial?